+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Atherectomy and Thrombectomy Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 306 Pages
  • January 2024
  • Region: Global
  • Fairfield Market Research
  • ID: 5927514
The global Atherectomy and Thrombectomy Devices Market is set to witness substantial growth from 2024 to 2031. The market is anticipated to expand from US$ 3.6 billion in 2026 to US$ 5.8 billion by 2031, according to a comprehensive analysis by the publisher, a leading market research firm.

Key Highlights:

  • The Atherectomy and Thrombectomy Devices Market is poised for notable growth between 2024 and 2031, with a steady projected Compound Annual Growth Rate (CAGR). During this period, the market is expected to experience considerable expansion, reaching a higher value in 2031 compared to 2024.
  • COVID-19 pandemic temporarily impacted the market; recovery expected as healthcare activities resume.
  • Minimally invasive surgeries and technological advancements drive market growth.
  • North America is the primary market leader, and the United States is expected to maintain a steady growth rate.
  • Asia Pacific poised for rapid growth, with Japan and China showing promising CAGR.

Impact of COVID-19:

The COVID-19 pandemic had a temporary impact on the market as several cardiovascular procedures and non-essential therapies were postponed. However, as healthcare activities gradually return to normal, the atherectomy and thrombectomy devices market is expected to regain momentum.

Driving Factors:

The growing preference for minimally invasive surgeries is a significant driver of the market. These procedures offer reduced pain, shorter hospital stays, and fewer complications. Atherectomy, a minimally invasive artery treatment, is in high demand due to its benefits.

Additionally, ongoing research, favorable medical reimbursement scenarios, and robust distribution systems contribute to market growth.

Challenges:

The scarcity of healthcare workers, particularly in rural areas, poses a challenge. The market's potential is hindered by a lack of trained professionals to handle these devices, coupled with stringent regulations.

Regional Outlook:

North America:

North America is poised to maintain the largest market share during the forecast period, driven by factors such as enhanced reimbursements for atherectomy systems, a substantial patient population dealing with peripheral and coronary artery diseases, the adoption of atherectomy systems by medical professionals, and a growing number of clinical trials.

The United States is expected to demonstrate a steady Compound Annual Growth Rate (CAGR) during the forecast period. In addition to the factors mentioned earlier, the increased interest of atherectomy device vendors in the region contributes to the heightened demand for these products.

Furthermore, government initiatives aimed at raising awareness and the necessity for improved healthcare infrastructure are propelling the atherectomy and thrombectomy devices market in North America throughout the forecast period.
  • Asia Pacific: The Asia Pacific atherectomy and thrombectomy devices market is projected to experience a more rapid growth rate during the forecast period, driven by enhancements in healthcare infrastructure, heightened patient awareness, and increased disposable income. Japan is expected to maintain a steady Compound Annual Growth Rate (CAGR) during this period, while China is anticipated to have a slightly higher CAGR by 2031.

Competitive Analysis:

Key players in the market prioritize collaborations, mergers, acquisitions, and innovation. Recent developments include:
  • Cardiovascular Systems Inc's Diamondback 360 Coronary Orbital Atherectomy System receiving CE mark with GlideAssist technology.
  • Koninklijke Philips N.V. launching the Philips Laser System for atherectomy treatments.
  • AngioDynamics introducing the Auryon Atherectomy System in the United States.
  • Medtronic applying for FDA approval for the TurboHawk Plus Directional Atherectomy System.
The global atherectomy and thrombectomy devices market is poised for robust growth, driven by factors such as the increasing prevalence of cardiovascular disorders and advancements in technology.

Key Segments

By Type

  • Rheolytic
  • Aspiration
  • Rotational
  • Ultrasound Device

By Application

  • Hospitals
  • Clinics
  • Others

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Atherectomy and Thrombectomy Devices Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Atherectomy and Thrombectomy Devices Market Outlook, 2018 - 2031
3.1. Global Atherectomy and Thrombectomy Devices Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Rheolytic
3.1.1.2. Aspiration
3.1.1.3. Rotational
3.1.1.4. Ultrasound Device
3.2. Global Atherectomy and Thrombectomy Devices Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Hospitals
3.2.1.2. Clinics
3.2.1.3. Others
3.3. Global Atherectomy and Thrombectomy Devices Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. North America
3.3.1.2. Europe
3.3.1.3. Asia Pacific
3.3.1.4. Latin America
3.3.1.5. Middle East & Africa
4. North America Atherectomy and Thrombectomy Devices Market Outlook, 2018 - 2031
4.1. North America Atherectomy and Thrombectomy Devices Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Rheolytic
4.1.1.2. Aspiration
4.1.1.3. Rotational
4.1.1.4. Ultrasound Device
4.2. North America Atherectomy and Thrombectomy Devices Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Hospitals
4.2.1.2. Clinics
4.2.1.3. Others
4.2.2. BPS Analysis/Market Attractiveness Analysis
4.3. North America Atherectomy and Thrombectomy Devices Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. U.S. Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2018 - 2031
4.3.1.2. U.S. Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2018 - 2031
4.3.1.3. Canada Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2018 - 2031
4.3.1.4. Canada Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2018 - 2031
4.3.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Atherectomy and Thrombectomy Devices Market Outlook, 2018 - 2031
5.1. Europe Atherectomy and Thrombectomy Devices Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Rheolytic
5.1.1.2. Aspiration
5.1.1.3. Rotational
5.1.1.4. Ultrasound Device
5.2. Europe Atherectomy and Thrombectomy Devices Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Hospitals
5.2.1.2. Clinics
5.2.1.3. Others
5.2.2. BPS Analysis/Market Attractiveness Analysis
5.3. Europe Atherectomy and Thrombectomy Devices Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Germany Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2018 - 2031
5.3.1.2. Germany Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2018 - 2031
5.3.1.3. U.K. Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2018 - 2031
5.3.1.4. U.K. Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2018 - 2031
5.3.1.5. France Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2018 - 2031
5.3.1.6. France Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2018 - 2031
5.3.1.7. Italy Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2018 - 2031
5.3.1.8. Italy Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2018 - 2031
5.3.1.9. Turkey Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2018 - 2031
5.3.1.10. Turkey Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2018 - 2031
5.3.1.11. Russia Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2018 - 2031
5.3.1.12. Russia Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2018 - 2031
5.3.1.13. Rest of Europe Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2018 - 2031
5.3.1.14. Rest of Europe Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2018 - 2031
5.3.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Atherectomy and Thrombectomy Devices Market Outlook, 2018 - 2031
6.1. Asia Pacific Atherectomy and Thrombectomy Devices Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Rheolytic
6.1.1.2. Aspiration
6.1.1.3. Rotational
6.1.1.4. Ultrasound Device
6.2. Asia Pacific Atherectomy and Thrombectomy Devices Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Hospitals
6.2.1.2. Clinics
6.2.1.3. Others
6.2.2. Others BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific Atherectomy and Thrombectomy Devices Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. China Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2018 - 2031
6.3.1.2. China Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2018 - 2031
6.3.1.3. Japan Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2018 - 2031
6.3.1.4. Japan Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2018 - 2031
6.3.1.5. South Korea Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2018 - 2031
6.3.1.6. South Korea Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2018 - 2031
6.3.1.7. India Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2018 - 2031
6.3.1.8. India Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2018 - 2031
6.3.1.9. Southeast Asia Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2018 - 2031
6.3.1.10. Southeast Asia Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2018 - 2031
6.3.1.11. Rest of Asia Pacific Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2018 - 2031
6.3.1.12. Rest of Asia Pacific Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2018 - 2031
6.3.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Atherectomy and Thrombectomy Devices Market Outlook, 2018 - 2031
7.1. Latin America Atherectomy and Thrombectomy Devices Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Rheolytic
7.1.1.2. Aspiration
7.1.1.3. Rotational
7.1.1.4. Ultrasound Device
7.2. Latin America Atherectomy and Thrombectomy Devices Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
7.2.1.1. Hospitals
7.2.1.2. Clinics
7.2.1.3. Others
7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Latin America Atherectomy and Thrombectomy Devices Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Brazil Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2018 - 2031
7.3.1.2. Brazil Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2018 - 2031
7.3.1.3. Mexico Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2018 - 2031
7.3.1.4. Mexico Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2018 - 2031
7.3.1.5. Argentina Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2018 - 2031
7.3.1.6. Argentina Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2018 - 2031
7.3.1.7. Rest of Latin America Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2018 - 2031
7.3.1.8. Rest of Latin America Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2018 - 2031
7.3.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Atherectomy and Thrombectomy Devices Market Outlook, 2018 - 2031
8.1. Middle East & Africa Atherectomy and Thrombectomy Devices Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Rheolytic
8.1.1.2. Aspiration
8.1.1.3. Rotational
8.1.1.4. Ultrasound Device
8.2. Middle East & Africa Atherectomy and Thrombectomy Devices Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Hospitals
8.2.1.2. Clinics
8.2.1.3. Others
8.2.2. BPS Analysis/Market Attractiveness Analysis
8.3. Middle East & Africa Atherectomy and Thrombectomy Devices Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. GCC Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2018 - 2031
8.3.1.2. GCC Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2018 - 2031
8.3.1.3. South Africa Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2018 - 2031
8.3.1.4. South Africa Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2018 - 2031
8.3.1.5. Egypt Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2018 - 2031
8.3.1.6. Egypt Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2018 - 2031
8.3.1.7. Nigeria Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2018 - 2031
8.3.1.8. Nigeria Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2018 - 2031
8.3.1.9. Rest of Middle East & Africa Atherectomy and Thrombectomy Devices Market by Type, Value (US$ Bn), 2018 - 2031
8.3.1.10. Rest of Middle East & Africa Atherectomy and Thrombectomy Devices Market by Application, Value (US$ Bn), 2018 - 2031
8.3.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Manufacturer vs by Application Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Medtronic
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. Boston Scientific
9.4.2.1. Company Overview
9.4.2.2. Product Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. Spectranetics
9.4.3.1. Company Overview
9.4.3.2. Product Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. Bayer AG
9.4.4.1. Company Overview
9.4.4.2. Product Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. Cardiovascular Systems
9.4.5.1. Company Overview
9.4.5.2. Product Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. Argon Medical Devices
9.4.6.1. Company Overview
9.4.6.2. Product Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. Getinge AB
9.4.7.1. Company Overview
9.4.7.2. Product Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. Straub Medical AG
9.4.8.1. Company Overview
9.4.8.2. Product Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
9.4.9. Teleflex
9.4.9.1. Company Overview
9.4.9.2. Product Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
9.4.10. Terumo Medical
9.4.10.1. Company Overview
9.4.10.2. Product Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development
9.4.11. Abbott
9.4.11.1. Company Overview
9.4.11.2. Product Portfolio
9.4.11.3. Financial Overview
9.4.11.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned

  • Medtronic
  • Boston Scientific
  • Spectranetics
  • Bayer AG
  • Cardiovascular Systems
  • Argon Medical Devices
  • Getinge AB
  • Straub Medical AG
  • Teleflex
  • Terumo Medical
  • Abbott

Methodology

Loading
LOADING...